Amsbio has introduced an expanded range of Skeletal Muscle Differentiation Kits designed to reproducibly convert pluripotent or embryonic stem cells into myoblasts with high regenerative potential.
Using a simple 3-step process of media changes and cell passaging – these advanced kits can typically achieve 70% MF20-positive myotubes. The highly efficient protocol employed by the kit does not require genetic intervention or cell sorting, thereby saving you valuable time.
Not only do Amsbio Skeletal Muscle Differentiation kits work with all pluripotent stem cell lines – they also yield a homogeneous and physiologically competent population of cells / cultures immediately suitable for screening and advanced drug discovery.
Amsbio can deliver Skeletal Muscle Differentiation kits from stock as well as offer custom/outsourcing services for generating skeletal muscle myoblasts from your iPSC line of interest that fits into any workflow whether you need myoblasts fast or made specifically for your target application.
For further information please visit https://www.amsbio.com/skeletal-muscle-differentiation or contact Amsbio on +31-72-8080244 / +44-1235-828200 / +1-617-945-5033 / info@amsbio.com
